Nanjing Meirui Pharma Co., Ltd.
-
Founded in:
1996-03-19 -
Country:
China -
Address:
No. 50, Xingang Avenue, Nanjing Economic and Technological Development Zone -
Tax NO.:
9132010060894355X2 -
Registered Funds:
173.452212 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Water-soluble pollen extract P5 |
It has anti-inflammatory and antiproliferative effects, as well as antispasmodic and spasmolytic effects on smooth muscle
More
It has anti-inflammatory and antiproliferative effects, as well as antispasmodic and spasmolytic effects on smooth muscle |
0 | ||
| Fat-soluble pollen extract EA10 |
It has anti-inflammatory and antiproliferative effects, as well as antispasmodic and spasmolytic effects on smooth muscle
More
It has anti-inflammatory and antiproliferative effects, as well as antispasmodic and spasmolytic effects on smooth muscle |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tolterodine tartrate |
Competitive M cholinergic receptor blocker, used to relieve symptoms of frequent urination, urgency and urge incontinence caused by overactive bladder. It has higher selectivity for bladder than salivary glands. After oral administration, it is metabolized by the liver into the active metabolite 5-hydroxymethyl derivative which plays the main pharmacological role. Its anticholinergic activity is similar to that of this product. Both are highly selective for M cholinergic receptors, and have very weak effects or affinity on receptors of other neurotransmitters and potential cell targets.
More
Competitive M cholinergic receptor blocker, used to relieve symptoms of frequent urination, urgency and urge incontinence caused by overactive bladder. It has higher selectivity for bladder than salivary glands. After oral administration, it is metabolized by the liver into the active metabolite 5-hydroxymethyl derivative which plays the main pharmacological role. Its anticholinergic activity is similar to that of this product. Both are highly selective for M cholinergic receptors, and have very weak effects or affinity on receptors of other neurotransmitters and potential cell targets. |
124937-52-6 | 37 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| RN,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine-L-(+)-tartrate |
Competitive M cholinergic receptor blockers are used to relieve symptoms of frequent urination, urgency, and urge incontinence caused by overactive bladder; they are more selective for the bladder than the salivary glands (suggested by animal experiments, but not yet clinically confirmed); after oral administration, they are metabolized by the liver into active metabolites, 5-hydroxymethyl derivatives, both of which are highly selective for M cholinergic receptors and have very weak effects or affinities on other neurotransmitter receptors and cellular targets.
More
Competitive M cholinergic receptor blockers are used to relieve symptoms of frequent urination, urgency, and urge incontinence caused by overactive bladder; they are more selective for the bladder than the salivary glands (suggested by animal experiments, but not yet clinically confirmed); after oral administration, they are metabolized by the liver into active metabolites, 5-hydroxymethyl derivatives, both of which are highly selective for M cholinergic receptors and have very weak effects or affinities on other neurotransmitter receptors and cellular targets. |
0 |